Corcept Therapeutics Incorporated (CORT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Corcept Therapeutics Incorporated, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 36.27x | 37.23x | 31.69x | 21.39x | 20.35x | 28.48x |
| P/B Ratio | 5.58x | 7.65x | 6.64x | 4.32x | 6.09x | 5.77x |
| P/S Ratio | 4.75x | 7.71x | 6.97x | 5.40x | 6.26x | 8.53x |
| Profitability | ||||||
| Gross Margin | 98.3% | 98.4% | 98.7% | 98.7% | 98.6% | 98.4% |
| Operating Margin | 5.9% | 20.3% | 22.2% | 28.0% | 34.0% | 36.2% |
| Net Margin | 13.1% | 20.7% | 22.0% | 25.2% | 30.7% | 30.0% |
| EBITDA Margin | 6.1% | 20.5% | 22.5% | 28.3% | 35.0% | 36.9% |
| Liquidity | ||||||
| Current Ratio | 2.92x | 3.35x | 4.39x | 6.89x | 5.60x | 10.07x |
| Quick Ratio | 2.85x | 3.26x | 4.31x | 6.80x | 5.50x | 9.97x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..